Fatih Köse

3.0k total citations
65 papers, 520 citations indexed

About

Fatih Köse is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Fatih Köse has authored 65 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 20 papers in Surgery. Recurrent topics in Fatih Köse's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Fatih Köse is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Fatih Köse collaborates with scholars based in Türkiye, United Kingdom and United States. Fatih Köse's co-authors include Özgür Özyılkan, Cem Önal, İ. Lale Atahan, Enis Özyar, Ahmet Sezer, Hüseyin Mertsoylu, Ali Ayberk Beşen, Uğur Selek, Soner Soylu and Ahmet Taner Sümbül and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and BMC Cancer.

In The Last Decade

Fatih Köse

57 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatih Köse Türkiye 13 161 148 143 143 94 65 520
Hiroki Ishibashi Japan 13 185 1.1× 137 0.9× 332 2.3× 131 0.9× 39 0.4× 70 667
Chih‐Long Chang Taiwan 14 45 0.3× 157 1.1× 117 0.8× 136 1.0× 61 0.6× 42 523
Kwang Sun Suh South Korea 11 83 0.5× 56 0.4× 86 0.6× 101 0.7× 96 1.0× 27 345
Ichiro Kasahara Japan 12 122 0.8× 63 0.4× 128 0.9× 49 0.3× 30 0.3× 19 362
Turgut Kaçan Türkiye 12 82 0.5× 152 1.0× 49 0.3× 43 0.3× 42 0.4× 42 354
Zerrin Calay Türkiye 15 106 0.7× 67 0.5× 125 0.9× 396 2.8× 67 0.7× 38 746
Andrew C. McGill United Kingdom 13 70 0.4× 59 0.4× 74 0.5× 107 0.7× 34 0.4× 26 500
Christine Bekos Austria 14 81 0.5× 108 0.7× 82 0.6× 26 0.2× 69 0.7× 36 418
Zuhat Urakçı Türkiye 11 148 0.9× 204 1.4× 75 0.5× 24 0.2× 69 0.7× 79 422
Yu Min China 14 68 0.4× 111 0.8× 125 0.9× 29 0.2× 88 0.9× 49 519

Countries citing papers authored by Fatih Köse

Since Specialization
Citations

This map shows the geographic impact of Fatih Köse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatih Köse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatih Köse more than expected).

Fields of papers citing papers by Fatih Köse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatih Köse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatih Köse. The network helps show where Fatih Köse may publish in the future.

Co-authorship network of co-authors of Fatih Köse

This figure shows the co-authorship network connecting the top 25 collaborators of Fatih Köse. A scholar is included among the top collaborators of Fatih Köse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatih Köse. Fatih Köse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vergote, Ignace, Mansoor Raza Mirza, Jalid Sehouli, et al.. (2022). 2022-RA-1548-ESGO Trial in progress update on ENGOT-cx8/GOG-3024/innovaTV 205: addition of a new cohort using first-line tisotumab vedotin + pembrolizumab + carboplatin ± bevacizumab in recurrent/metastatic cervical cancer. International Journal of Gynecological Cancer. 32. A64–A64. 1 indexed citations
3.
Köse, Fatih, et al.. (2021). Survival outcome of pulmonary metastasectomy among the patients with colorectal cancers. Revista da Associação Médica Brasileira. 67(7). 1015–1020. 2 indexed citations
4.
Doğan, Mutlu, Mehmet Artaç, Levent Korkmaz, et al.. (2021). The Relationship Between Plexin C1 Overexpression and Survival in Hepatocellular Carcinoma: a Turkish Oncology Group (TOG) Study. Journal of Gastrointestinal Cancer. 53(2). 356–362. 3 indexed citations
5.
Kuş, Tülay, Fatih Köse, Gökmen Aktaş, et al.. (2020). Prediction of Peritoneal Recurrence in Patients with Gastric Cancer: a Multicenter Study. Journal of Gastrointestinal Cancer. 52(2). 634–642. 10 indexed citations
6.
Yıldırım, Berna Akkuş, Cem Önal, Fatih Köse, et al.. (2019). Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. Strahlentherapie und Onkologie. 195(10). 872–881. 9 indexed citations
7.
8.
9.
Mertsoylu, Hüseyin, Ali Ayberk Beşen, Ahmet Sezer, et al.. (2014). Primary Extranodal Non-Hodgkin's Lymphoma: Clinicopathological Features, Survival and Treatment Outcome in Two Cancer Centers of Southern Turkey. Asian Pacific Journal of Cancer Prevention. 15(17). 7207–7211. 7 indexed citations
10.
Dişel, Umut, Ali Ayberk Beşen, Hüseyin Mertsoylu, et al.. (2012). Prevalence of thyroid dysfunction in untreated cancer patients: a cross-sectional study. Medical Oncology. 29(5). 3608–3613. 8 indexed citations
11.
Sümbül, Ahmet Taner, et al.. (2012). Successful Treatment of Aortic Rupture with Endovascular Stent Grafting in a Patient with Mantle Cell Lymphoma. Case Reports in Oncology. 5(2). 275–279. 2 indexed citations
12.
Dişel, Umut, Serdar Öztuzcu, Ali Ayberk Beşen, et al.. (2010). Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation. Lung Cancer. 71(1). 109–112. 26 indexed citations
13.
Köse, Fatih, Ali Ayberk Beşen, Saime Paydaş, et al.. (2009). Effects of selective Cox-2 inhibitor, rofecoxib, alone or combination with furosemide on renal functions and renal Cox-2 expression in rats. Clinical and Experimental Nephrology. 14(1). 22–27. 6 indexed citations
14.
Köse, Fatih, Hüseyin Mertsoylu, Ahmet Sezer, et al.. (2009). Primary Renal Lymphoma: Report of Four Cases. Oncology Research and Treatment. 32(4). 200–202. 17 indexed citations
15.
Köse, Fatih, et al.. (2008). Colon Adenocarcinoma and Solitary Tibia Metastasis: Rare Entity. Journal of Gastrointestinal Cancer. 39(1-4). 146–148. 6 indexed citations
16.
Atahan, İ. Lale, et al.. (2007). Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study. International Journal of Gynecological Cancer. 17(4). 833–842. 78 indexed citations
17.
Paydaş, Saime, et al.. (2006). Renal Function in Patients with Orthotopic Liver Transplantation. Renal Failure. 28(2). 103–105. 4 indexed citations
18.
Yüce, K., et al.. (2006). Correlation of serum and ascitic IL-12 levels with second-look laparotomy results and disease progression in advanced epithelial ovarian cancer patients. International Journal of Gynecological Cancer. 16(1). 83–86. 6 indexed citations
19.
Oto, Özgür Akın, Semra Paydaş, Fikri Başlamıslı, et al.. (2006). Transfusion-associated graft-versus-host disease. European Journal of Internal Medicine. 17(3). 151–156. 5 indexed citations
20.
Arvas, Macit, Fatih Köse, Altay Gezer, et al.. (2004). Radical versus conservative surgery for vulvar carcinoma. International Journal of Gynecology & Obstetrics. 88(2). 127–133. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroki Ishibashi Breakdown of academic impact, for papers by Chih‐Long Chang Breakdown of academic impact, for papers by Kwang Sun Suh Breakdown of academic impact, for papers by Ichiro Kasahara Breakdown of academic impact, for papers by Turgut Kaçan Breakdown of academic impact, for papers by Zerrin Calay Breakdown of academic impact, for papers by Andrew C. McGill Breakdown of academic impact, for papers by Christine Bekos Breakdown of academic impact, for papers by Zuhat Urakçı Breakdown of academic impact, for papers by Yu Min
Rankless by CCL
2026